These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

177 related items for PubMed ID: 34360793

  • 1. Ligand-Dependent and Ligand-Independent Effects of Ephrin-B2-EphB4 Signaling in Melanoma Metastatic Spine Disease.
    Piffko A, Broggini T, Harms C, Adams RH, Vajkoczy P, Czabanka M.
    Int J Mol Sci; 2021 Jul 27; 22(15):. PubMed ID: 34360793
    [Abstract] [Full Text] [Related]

  • 2. Ephrin-B2-EphB4 communication mediates tumor-endothelial cell interactions during hematogenous spread to spinal bone in a melanoma metastasis model.
    Broggini T, Piffko A, Hoffmann CJ, Ghori A, Harms C, Adams RH, Vajkoczy P, Czabanka M.
    Oncogene; 2020 Nov 27; 39(47):7063-7075. PubMed ID: 32989254
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Interplay between EphB4 on tumor cells and vascular ephrin-B2 regulates tumor growth.
    Noren NK, Lu M, Freeman AL, Koolpe M, Pasquale EB.
    Proc Natl Acad Sci U S A; 2004 Apr 13; 101(15):5583-8. PubMed ID: 15067119
    [Abstract] [Full Text] [Related]

  • 5. Ephrin B2/EphB4 mediates the actions of IGF-I signaling in regulating endochondral bone formation.
    Wang Y, Menendez A, Fong C, ElAlieh HZ, Chang W, Bikle DD.
    J Bone Miner Res; 2014 Aug 13; 29(8):1900-13. PubMed ID: 24677183
    [Abstract] [Full Text] [Related]

  • 6. Sinusoidal ephrin receptor EPHB4 controls hematopoietic progenitor cell mobilization from bone marrow.
    Kwak H, Salvucci O, Weigert R, Martinez-Torrecuadrada JL, Henkemeyer M, Poulos MG, Butler JM, Tosato G.
    J Clin Invest; 2016 Dec 01; 126(12):4554-4568. PubMed ID: 27820703
    [Abstract] [Full Text] [Related]

  • 7. The EphB4 receptor promotes the growth of melanoma cells expressing the ephrin-B2 ligand.
    Yang NY, Lopez-Bergami P, Goydos JS, Yip D, Walker AM, Pasquale EB, Ethell IM.
    Pigment Cell Melanoma Res; 2010 Oct 01; 23(5):684-7. PubMed ID: 20649938
    [No Abstract] [Full Text] [Related]

  • 8. Activation of the receptor EphB4 by its specific ligand ephrin B2 in human osteoarthritic subchondral bone osteoblasts.
    Kwan Tat S, Pelletier JP, Amiable N, Boileau C, Lajeunesse D, Duval N, Martel-Pelletier J.
    Arthritis Rheum; 2008 Dec 01; 58(12):3820-30. PubMed ID: 19035475
    [Abstract] [Full Text] [Related]

  • 9. The protective role of Ephrin-B2/EphB4 signaling in osteogenic differentiation under inflammatory environment.
    Qu F, Song Y, Wu Y, Huang Y, Zhong Q, Zhang Y, Fan Z, Xu C.
    Exp Cell Res; 2021 Mar 15; 400(2):112505. PubMed ID: 33516666
    [Abstract] [Full Text] [Related]

  • 10. Divergent Roles of Ephrin-B2/EphB4 Guidance System in Pulmonary Hypertension.
    Crnkovic S, Rittchen S, Jandl K, Gindlhuber J, Zabini D, Mutgan AC, Valzano F, Boehm PM, Hoetzenecker K, Toller W, Veith C, Heinemann A, Schermuly RT, Olschewski A, Marsh LM, Kwapiszewska G.
    Hypertension; 2023 Feb 15; 80(2):e17-e28. PubMed ID: 36519465
    [Abstract] [Full Text] [Related]

  • 11. Distinct roles of ephrin-B2 forward and EphB4 reverse signaling in endothelial cells.
    Hamada K, Oike Y, Ito Y, Maekawa H, Miyata K, Shimomura T, Suda T.
    Arterioscler Thromb Vasc Biol; 2003 Feb 01; 23(2):190-7. PubMed ID: 12588758
    [Abstract] [Full Text] [Related]

  • 12. Inhibition of EphB4-Ephrin-B2 Signaling Reprograms the Tumor Immune Microenvironment in Head and Neck Cancers.
    Bhatia S, Oweida A, Lennon S, Darragh LB, Milner D, Phan AV, Mueller AC, Van Court B, Raben D, Serkova NJ, Wang XJ, Jimeno A, Clambey ET, Pasquale EB, Karam SD.
    Cancer Res; 2019 May 15; 79(10):2722-2735. PubMed ID: 30894369
    [Abstract] [Full Text] [Related]

  • 13. Inhibition of EphB4-Ephrin-B2 Signaling Enhances Response to Cetuximab-Radiation Therapy in Head and Neck Cancers.
    Bhatia S, Sharma J, Bukkapatnam S, Oweida A, Lennon S, Phan A, Milner D, Uyanga N, Jimeno A, Raben D, Somerset H, Heasley L, Karam SD.
    Clin Cancer Res; 2018 Sep 15; 24(18):4539-4550. PubMed ID: 29848571
    [Abstract] [Full Text] [Related]

  • 14. Ephrin-independent regulation of cell substrate adhesion by the EphB4 receptor.
    Noren NK, Yang NY, Silldorff M, Mutyala R, Pasquale EB.
    Biochem J; 2009 Aug 27; 422(3):433-42. PubMed ID: 19552627
    [Abstract] [Full Text] [Related]

  • 15. Ephrin B2 and EphB4 selectively mark arterial and venous vessels in cerebral arteriovenous malformation.
    Bai J, Wang YJ, Liu L, Zhao YL.
    J Int Med Res; 2014 Apr 27; 42(2):405-15. PubMed ID: 24517927
    [Abstract] [Full Text] [Related]

  • 16. Combination of Dll4/Notch and Ephrin-B2/EphB4 targeted therapy is highly effective in disrupting tumor angiogenesis.
    Djokovic D, Trindade A, Gigante J, Badenes M, Silva L, Liu R, Li X, Gong M, Krasnoperov V, Gill PS, Duarte A.
    BMC Cancer; 2010 Nov 23; 10():641. PubMed ID: 21092311
    [Abstract] [Full Text] [Related]

  • 17. EphB4 promotes site-specific metastatic tumor cell dissemination by interacting with endothelial cell-expressed ephrinB2.
    Héroult M, Schaffner F, Pfaff D, Prahst C, Kirmse R, Kutschera S, Riedel M, Ludwig T, Vajkoczy P, Graeser R, Augustin HG.
    Mol Cancer Res; 2010 Oct 23; 8(10):1297-309. PubMed ID: 21047731
    [Abstract] [Full Text] [Related]

  • 18. Preponderance of cells with stem cell characteristics in metastasising mouse mammary tumours induced by deregulated EphB4 and ephrin-B2 expression.
    Kaenel P, Schwab C, Mülchi K, Wotzkow C, Andres AC.
    Int J Oncol; 2011 Jan 23; 38(1):151-60. PubMed ID: 21109936
    [Abstract] [Full Text] [Related]

  • 19. Spatiomechanical Modulation of EphB4-Ephrin-B2 Signaling in Neural Stem Cell Differentiation.
    Dong M, Spelke DP, Lee YK, Chung JK, Yu CH, Schaffer DV, Groves JT.
    Biophys J; 2018 Sep 04; 115(5):865-873. PubMed ID: 30075851
    [Abstract] [Full Text] [Related]

  • 20. EphrinB2-EphB4 Signaling in Neurooncological Disease.
    Piffko A, Uhl C, Vajkoczy P, Czabanka M, Broggini T.
    Int J Mol Sci; 2022 Jan 31; 23(3):. PubMed ID: 35163601
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.